XDx, Inc. · Brisbane, CA United States
Company Description
View XDx, Inc. Locations On A US Map
This link will open in a new window
This link will open in a new window Rejection hurts, but organ transplant rejection hurts worse, and XDx wants to help. The company makes tests that monitor for cellular rejection in heart transplants. Its FDA-approved AlloMap test measures gene expression in patients' blood samples to determine if a transplanted heart has been accepted. The company believes its tests will help reduce costs by decreasing the number of biopsies and drug therapies often used in evaluating transplants in patients. XDx also has explored the development of AlloMap for lung transplant patients, and it has other molecular (gene-based) diagnostic research programs in areas such as immunology. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key XDx, Inc. Financials
| Company Type | Private Single Location |
| Fiscal Year-End | December |
| Annual Sales (mil.) | $2.5 |
| Employees | 20 |
XDx, Inc. Executives
14 executives listed for XDx, Inc.'s Brisbane, CA location.
| Title | Name & Bio | Contact |
| Chairman | Brook Byers | Network |
| President, CEO, and Director | Pierre Cassigneul | Network |
| VP, Information Sciences | Tod Klingler | Network |
Competition
Competitive Landscape for XDx, Inc.
Demand is driven by population demographics and advances in medical knowledge and technology. The profitability of individual companies depends on the ability to develop superior products. Large companies have economies of scale in manufacturing and R&D. Small companies can compete successfully by specializing in a particular market segment, or through technical innovation. To read the full description, subscribe now.Top XDx, Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!